# HDDO-1801 Intervention Trial

> **NCT04097951** · PHASE1 · UNKNOWN · sponsor: **Hyundai Pharmaceutical Co., LTD.** · enrollment: 36 (estimated)

## Conditions studied

- Respiratory Disease

## Interventions

- **DRUG:** Combinations

## Key facts

- **NCT ID:** NCT04097951
- **Lead sponsor:** Hyundai Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-08
- **Primary completion:** 2020-01-08
- **Final completion:** 2020-02-28
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2019-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04097951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04097951, "HDDO-1801 Intervention Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04097951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*